Hydroxy isovaleryl

C5-OH 3-Hydroxy isovaleryl- Biotinidase deficiency, HMG deficiency, MCC deficiency, MCD deficiency, MGA deficiency... 

Conversion of the blastmycinolactol diastereomers to the corresponding blastmycinones should be achievable by acylation of the free hydroxy group with isovaleryl chloride, as shown in Scheme 77 (Section 1.5.1). 

Inhibitor peptides low molecular mass oligopeptide-fatty acid compounds of microbial origin which irreversibly inactivate plant and animal proteases. The inhibition is stoichiometric, i.e. 1 molecule I.p. inhibits 1 molecule enzyme. Examples are Leupeptin [acetyl-(or propionyl-)L-Leu-L-Leu-arginal the L-leu-cine can also be replaced by L-isovaline or L-valine], from Streptomyces species, inhibits cathepsin B, papain, trypsin, plasmin and cathepsin D, the effectiveness of the inhibition decreasing in that order. Pepsta-tin (isovaleryl-L-Val-L-Val-P-hydroxy-Y-NH2- -CH3-heptanoyl-L-Ala-P-hydroxy-Y-NHj-e-heptanoic acid), from actinomycetes, inhibits pepsin and cathepsin D. Chymostatin inhibits all known chymotrypsin types, cathepsin A, B, and D and papain. Antipain inhibits papain trypsin and plasmin. 

Isovaleryl CoA is oxidized in a reaction similar to that found for other acyl CoA compounds to senecioyl CoA. This imsaturated thioester is a substrate for crotonase and is hydrated to j3-hydrosyisovaleryl CoA (HIV CoA). An unusual type of reaction converts this product to /3-hydroxy- 8-methyl glutaryl CoA (HMG CoA). Free CO2 is not fixed directly, but is first activated in a reaction with ATP. The activating enzyme H enzyme was purified as a hydroxylamine and bicarbonate dependent ATP-splitting enzyme the initial products are believed to be AMP-CO2 and pyrophosphate. This enzyme is different from a fluoride, bicarbonate dependent ATPase that has been shown to form... 

The inborn errors of L-leucine catabolism present biochemically with branched-chain amino and/or organic aciduria [1]. These disorders include maple syrup disease (MSD branched-chain a-ketoacid dehydrogenase (BCKD) deficiency), isovaleric acidemia (isovaleryl-coenzyme A (CoA) dehydrogenase deficiency), isolated 3-methylcrotonyl-CoA carboxylase deficiency, the 3-methylglutaconic acidurias (3-methylglutaconyl-CoA hydratase deficiency, Barth syndrome, and other disorders in which the primary defect has not been demonstrated), and 3-hydroxy-3-methylglutaric aciduria (3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) lyase deficiency). 

Figure I. Acyl

Pepstatin is a low molecular weight, potent inhibitor specific for acid proteases with a value of about 10" M for pepsin. The chemical structure of pepstatin is essentially a hexapeptide which contains two residues of an unusual amino acid, 4-amino-3-hydroxy-6-methylheptanoic acid (statine). The complete structure of pepstatin is isovaleryl-L-valyl-L-valyl-statyl-L-alanyl-statine. 

Endogenous production of HMB occurs in muscle and liver (Figure 12.1) and possibly other tissues. The first step in HMB formation is the transamination of leucine to KIC, which occurs in both the cytosol and mitochondria of muscle cells. In the mitochondria, KIC is irreversibly oxidized to isovaleryl-CoA by the enzyme branched-chain a-keto acid dehydrogenase. Isovaleryl-CoA then undergoes further metabolic steps within the mitochondria (Figure 12.1), yielding P-hydroxy- -methylglutaryl-CoA (HMG-CoA). Further metabolism by the enzyme HMG-CoA lyase results in the end products acetoacetate and acetyl-CoA. Approximately 90% of KIC is oxidized to isovaleryl CoA in liver mitochondria and ultimately to acetoacetate and acetyl-CoA. 

Also obtained by Friedel-Crafts acylation of p-hydroxy-acetophenone with isovaleryl chloride (4 mol) in tetrachloroethane at 130° for 4 h (37%) [5626]. 

N.B. After several days in a CDCI3 solution nsed for the H NMR measnre-ments, 3-(3-hydroxy-3-methyl-l-butenyl)-5-isovaleryl-p-hydroxy-acetophenone (E) was converted into the titled substance [5946],... 

The synthetic technique is summarized in Scheme 3. Reaction of chaparrin (41b) with tert-butyldimethylsilyl chloride 11) afforded the crystalline disilyl derivative (93). The latter was obtained in better yield by silylation of (41b) with tert-butyldimethylsilyl enol ether of pentane-2,4-dione 105). The hydroxyl function at C-1 of (93) was effectively protected using trimethylsilyl triflate to afford the trisilyl lactone (94) which upon treatment with lithium diisopropylamide (LDA) and subsequent exposure to MoOs-pyridine-HMPA (M0O5PH) 104) gave the required 15-hydroxy lactone (95). Treatment of the latter with isovaleryl chloride afforded the crystalline ester (96) which was selectively desilylated to (97). Oxidation of the free allylic hydroxyl and complete desilylation of the resulting disilyl enone with tetrabutylammonium fluoride (BU4NF) afforded the natural cytotoxic quassinoid castelanone (34). 

---